Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCIC CTG MA.32
Show Display Options
Rank Status Study
1 Active, not recruiting Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
Conditions: Breast Cancer;   Depression;   Fatigue;   Sleep Disorders
Interventions: Drug: Metformin;   Drug: Placebo

Indicates status has not been verified in more than two years